Department of Medicine, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.
Br J Cancer. 2010 Feb 16;102(4):629-38. doi: 10.1038/sj.bjc.6605527. Epub 2010 Jan 26.
Small cell lung cancer (SCLC) is a significant health problem worldwide because of its high propensity for relapse. This review discusses existing and future therapies for the treatment of SCLC.
小细胞肺癌(SCLC)是一个严重的全球健康问题,因为它具有很高的复发倾向。本文讨论了目前和未来用于治疗 SCLC 的疗法。